{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:20:07Z","timestamp":1792268407819,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.medcli.2021.12.006","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T17:04:49Z","timestamp":1642179889000},"page":"359-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1700-4329","authenticated-orcid":false,"given":"Jos\u00e9 E.","family":"Oller-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Vicens Bernabeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Gonzalez-Mazar\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grau Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M.","family":"Ortiz Sanjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Rom\u00e1n Ivorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2021.12.006_bib0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.medcli.2021.12.006_bib0160","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.medcli.2021.12.006_bib0165","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fimmu.2018.01702","article-title":"Innate immunity in systemic sclerosis fibrosis: recent advances","volume":"9","author":"Laurent","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1688470","article-title":"Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides","volume":"247","author":"Maione","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.medcli.2021.12.006_bib0175","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2021.12.006_bib0180","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","article-title":"Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium","volume":"105","author":"Von Hundelshausen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2021.12.006_bib0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13075-016-1203-y","article-title":"Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease","volume":"18","author":"Volkmann","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.medcli.2021.12.006_bib0190","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kew251","article-title":"Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?","volume":"55","author":"Van Bon","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2021.12.006_bib0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.matbio.2006.01.007","article-title":"Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts","volume":"25","author":"Farina","year":"2006","journal-title":"Matrix Biol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0200","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"Van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2021.12.006_bib0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10238-016-0437-y","article-title":"CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc)","volume":"17","author":"Valentini","year":"2017","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.medcli.2021.12.006_bib0210","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.3390\/ijms21145102","article-title":"Anti-CXCL4 antibody reactivity is present in systemic sclerosis (SSc) and correlates with the SSc type I interferon signature","volume":"21","author":"Lande","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2021.12.006_bib0215","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmocytoid dendritic cells promote systemic sclerosis with a key role fot TLR8","volume":"10","author":"Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.medcli.2021.12.006_bib0220","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1378\/chest.10-0302","article-title":"Increased expression of growth differentiation factor 15 in systemic sclerosis associated pulmonary arterial hypertension","volume":"139","author":"Meadows","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.medcli.2021.12.006_bib0225","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1164\/rccm.200712-1786OC","article-title":"Growth differentiation factor 15 for prognostic assessment of patients with acute pulmonary embolism","volume":"177","author":"Lankeit","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2021.12.006_bib0230","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3109\/s10165-011-0568-7","article-title":"Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity","volume":"22","author":"Yanaba","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20100370","article-title":"Growth differentiation factor-15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis","volume":"208","author":"De Jager","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.medcli.2021.12.006_bib0240","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.38241","article-title":"Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development","volume":"66","author":"Lambrecht","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","article-title":"The transforming growth factor-\u03b2 family","volume":"6","author":"Massagu\u00e9 J:","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0250","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.medcli.2021.12.006_bib0255","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cyto.2012.05.026","article-title":"Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis","volume":"60","author":"Salim","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.medcli.2021.12.006_bib0265","first-page":"3575803","article-title":"Cross-disease innate gene signature: emerging diversity and abundance in RA comparing to SLE and SSc","author":"Petrackova","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.medcli.2021.12.006_bib0270","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/s10165-012-0795-6","article-title":"Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study","volume":"23","author":"Hasegawa","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0275","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.rmed.2013.03.015","article-title":"Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis","volume":"107","author":"Hesselstrand","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.medcli.2021.12.006_bib0280","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"Suppl. 1253","key":"10.1016\/j.medcli.2021.12.006_bib0285","first-page":"53","article-title":"Comparison of the disease activity score and the revised EUSTAR activity index in diffuse cutaneous systemic sclerosis patients","volume":"38","author":"Doyen","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0290","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/08820139.2017.1360340","article-title":"Growth differentiation factor-15 (GDF-15) level and relation to clinical manifestations in Egyptian systemic sclerosis patients: preliminary data","volume":"46","author":"Gamal","year":"2017","journal-title":"Immunol Invest"},{"key":"10.1016\/j.medcli.2021.12.006_bib0295","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3389\/fimmu.2018.02385","article-title":"Complement C3 produced by macrophages promotes renal fibrosis via IL-17A secretion","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2021.12.006_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajplung.00395.2017","article-title":"The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis","volume":"315","author":"Okamoto","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321007375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321007375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:54:50Z","timestamp":1758419690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775321007375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0025775321007375"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2021.12.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}